THERESA PEEK: Open Payments
NPI 1841593381 · MORGANFIELD, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$825 in 39 payments from 11 companies in 2025. Trend: 2023 $657 · 2024 $792 · 2025 $825
Food & beverage: $650Consulting: $175
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 5 | $236 |
| ABBVIE INC. | 15 | $202 |
| AstraZeneca Pharmaceuticals LP | 6 | $169 |
| PFIZER INC. | 3 | $43 |
| Novo Nordisk Inc | 2 | $34 |
| Lilly USA, LLC | 2 | $33 |
| Otsuka America Pharmaceutical, Inc. | 2 | $32 |
| Vanda Pharmaceuticals Inc. | 1 | $23 |
| Insulet Corporation | 1 | $22 |
| Lundbeck LLC | 1 | $16 |
Products named: PROLIA, UBRELVY, FARXIGA, VRAYLAR, AIRSUPRA, OTEZLA, REXULTI, QULIPTA.
Industry payments across KY — which companies pay providers there.
